AKZO NOBEL SPONS.ADRS 1/3 Cash Flow-to-Debt Ratio
AKZO NOBEL SPONS.ADRS 1/3 cash flow-to-debt ratio. AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of €170.00 Million could theoretically repay 0% of its total liabilities (€11.10 Billion) in one year. Check earnings quality score of AKZO NOBEL SPONS.ADRS 1/3 to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
Cash flow-to-debt ratio of AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025. Historical debt coverage capacity for AKZO NOBEL SPONS.ADRS 1/3 across 4 annual periods. Check AKZO NOBEL SPONS.ADRS 1/3 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
AKZO NOBEL SPONS.ADRS 1/3 Cash Flow-to-Debt Ratio by Year (2022–2025)
AKZO NOBEL SPONS.ADRS 1/3 cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for AKZO NOBEL SPONS.ADRS 1/3. For the full cash flow conversion analysis, see AKUP operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €915.00 Million | €9.13 Billion | ▲ +40.5% |
| 2024 | 0.07x | €673.00 Million | €9.43 Billion | ▼ -36.6% |
| 2023 | 0.11x | €1.13 Billion | €10.01 Billion | ▲ +335.9% |
| 2022 | 0.03x | €263.00 Million | €10.19 Billion | — |